502 related articles for article (PubMed ID: 31368254)
1. Characteristics and risk factors for pulmonary arterial hypertension associated with primary Sjögren's syndrome: 15 new cases from a single center.
Zhang N; Zhao Y; Wang H; Sun W; Chen M; Fan Q; Yang Z; Wei W
Int J Rheum Dis; 2019 Sep; 22(9):1775-1781. PubMed ID: 31368254
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjögren's syndrome.
Yan S; Li M; Wang H; Yang X; Zhao J; Wang Q; Liu Y; Lai J; Tian Z; Song H; Zhao Y; Zeng X
Int J Rheum Dis; 2018 May; 21(5):1068-1075. PubMed ID: 29624870
[TBL] [Abstract][Full Text] [Related]
3. The prognosis of pulmonary arterial hypertension associated with primary Sjögren's syndrome: a cohort study.
Liu Z; Yang X; Tian Z; Qian J; Wang Q; Zhao J; Huang C; Liu Y; Guo X; Wang H; Lai J; Li M; Zhao Y; Zeng X
Lupus; 2018 Jun; 27(7):1072-1080. PubMed ID: 29419347
[TBL] [Abstract][Full Text] [Related]
4. [Primary Sjogren's syndrome associated pulmonary arterial hypertension: 20 new cases].
Zhao Y; Wang H; Chen M; Zhang N; Yang ZW; Li D; Wei W
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(37):2921-2925. PubMed ID: 31607022
[No Abstract] [Full Text] [Related]
5. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature.
Launay D; Hachulla E; Hatron PY; Jais X; Simonneau G; Humbert M
Medicine (Baltimore); 2007 Sep; 86(5):299-315. PubMed ID: 17873760
[TBL] [Abstract][Full Text] [Related]
6. Is it possible to apply the treat-to-target strategy in primary Sjögren's syndrome-associated pulmonary arterial hypertension?
Liu Z; Wang J; Lai J; Wang Q; Zhao J; Huang C; Yang X; Qian J; Wang H; Guo X; Liu Y; Tian Z; Li M; Zhao Y; Zeng X
Clin Rheumatol; 2018 Nov; 37(11):2989-2998. PubMed ID: 30039269
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary arterial hypertension associated with primary Sjögren's syndrome: a multicentre cohort study from China.
Wang J; Li M; Wang Q; Zhang X; Qian J; Zhao J; Xu D; Tian Z; Wei W; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wang Y; Zhao Y; Zeng X
Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32616590
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and risk factors for primary Sjögren
Chen Z; Tian J; Ouyang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):339-346. PubMed ID: 37164917
[TBL] [Abstract][Full Text] [Related]
9. Severe pulmonary arterial hypertension and massive ascites in a patient with systemic lupus erythematosus and secondary Sjogren's syndrome.
Yucel H; Vollmer O; Canuet M; Enache I; Kessler R; Korganow AS; Riou M
Lupus; 2021 Mar; 30(3):510-513. PubMed ID: 33655792
[TBL] [Abstract][Full Text] [Related]
10. Red blood cell distribution width as a potential predictor of survival of pulmonary arterial hypertension associated with primary Sjogren's syndrome: a retrospective cohort study.
Hui M; Zhao J; Tian Z; Wang J; Qian J; Yang X; Wang Q; Li M; Zhao Y; Zeng X
Clin Rheumatol; 2019 Feb; 38(2):477-485. PubMed ID: 30218288
[TBL] [Abstract][Full Text] [Related]
11. Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.
Huang C; Li M; Liu Y; Wang Q; Guo X; Zhao J; Lai J; Tian Z; Zhao Y; Zeng X
Medicine (Baltimore); 2016 Mar; 95(10):e2761. PubMed ID: 26962774
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.
Zhao J; Wang Q; Liu Y; Tian Z; Guo X; Wang H; Lai J; Huang C; Yang X; Li M; Zeng X
Int J Cardiol; 2017 Jun; 236():432-437. PubMed ID: 28159359
[TBL] [Abstract][Full Text] [Related]
14. [Lung involvement of primary Sjögren's syndrome].
Yan SM; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jul; 31(7):513-6. PubMed ID: 19035231
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary vasodilators can lead to various complications in pulmonary "arterial" hypertension associated with congenital heart disease.
Chida-Nagai A; Sagawa K; Tsujioka T; Fujimoto T; Taniguchi K; Sasaki O; Izumi G; Yamazawa H; Masaki N; Manabe A; Takeda A
Heart Vessels; 2020 Sep; 35(9):1307-1315. PubMed ID: 32285188
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential susceptibility genes in patients with primary Sjögren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing.
Li M; Shi Y; Zhao J; Wang Q; Li M; Zhao X
Arthritis Res Ther; 2023 Sep; 25(1):175. PubMed ID: 37730603
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAI.
Heus A; Arends S; Van Nimwegen JF; Stel AJ; Nossent GD; Bootsma H
Scand J Rheumatol; 2020 Jan; 49(1):38-46. PubMed ID: 31556344
[No Abstract] [Full Text] [Related]
19. Treatment Discontinuation or Interruption in Pulmonary Arterial Hypertension.
Narechania S; Torbic H; Tonelli AR
J Cardiovasc Pharmacol Ther; 2020 Mar; 25(2):131-141. PubMed ID: 31594400
[TBL] [Abstract][Full Text] [Related]
20. Influence of long-standing pulmonary arterial hypertension and its severity on pulmonary artery aneurysm development.
Nuche J; Montero-Cabezas JM; Lareo A; Huertas S; Jiménez López-Guarch C; Velázquez Martín M; Alonso Charterina S; Revilla Ostolaza Y; Delgado JF; Arribas Ynsaurriaga F; Escribano Subías P
Heart Vessels; 2020 Sep; 35(9):1290-1298. PubMed ID: 32248253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
